Training and Education

Shaping the science of oncology

Dr Fiona McLaughlin is the new Chief Scientific Officer of Avacta’s Therapeutics Division. She talks to Karen Southern about her mission to develop first and best-in-class cancer drugs. From the day that Dr McLaughlin – then a biochemistry student –...

Biotech pioneer tackles the biology of ageing

Living to a ripe old age is one thing. Enjoying a healthy, ripe old age is the challenge. Biotech veteran Dr Eric Leire aims to slow ageing by design, as he explains to Karen Southern. The quest for immortality (or...

Euro biotech: breaking down the barriers to a golden age

Converting cutting-edge research into viable products remains a challenge for the European biotech sector. Jonathan Hay of Delin Ventures investigates how ambition can translate to reality. Europe’s tech sector is going from strength to strength. The Covid-19 pandemic – and...

Biosample provenance: what researchers need to know

Why is the current system for sourcing samples broken? And what does this mean for researchers who use biosamples? Robert Hewitt, MB BS, PhD, of Biosample Hub, investigates. The journey for every biospecimen used for medical research is different. It...

Pioneering breakthrough in treatment of ‘devastating’ neurological disorder

IntraBio Inc has announced positive data from its multinational clinical trial of IB1001 for the treatment of GM2 Gangliosidosis (Tay-Sachs and Sandhoff disease). IB1001 demonstrated a statistically significant and clinically meaningful improvement in symptoms, functioning, and quality of life in...

Covid portal start-up exceeds 1 million tests and creates offshoot venture

As the UK continues learning how to live with the pandemic, some key questions remain. Chiefly, how will the NHS grapple with the huge diagnosis and treatment backlog that has built up, and will the NHS become even more...

New clinical study into R-ketamine use for Treatment Resistant Depression

A clinical study to evaluate the safety and efficacy of PCN-101 (R-ketamine) has entered a new phase. R-ketamine is a stereoisomer of ketamine being developed for therapeutic treatment of psychiatric disorders such as Treatment Resistant Depression (TRD). The Phase 2a clinical...

Cleaning breakthrough for listeria elimination

All traces of listeria spp in a highly sensitive food production environment have been successfully eliminated in a breakthrough pilot. The 11-week proof of concept saw Bio-Fence antimicrobial coatings applied to the floor and lower part of walls of a...

AI could improve diagnosis for over 100,000 prostate patients in UK

The use of AI to identify prostate cancer is currently being validated in the first retrospective study of its kind in the UK. Real-world data from hospitals and scanner types is being scrutinised, to show how the technology could improve...

Advances in longitudinal RWD and genomics access for drug development in Africa

A new partnership aims to build the largest integrated clinical and genomics data biobank in Africa, representing a major boost for RWD research across the continent. The collaboration is between BC Platforms (BCP), a global leader in genomics research, analytics...

Ultrapure water system passes big test

An innovative ultrapure water system has successfully tapped into healthcare diagnostics. The pharmaceutical industry is embracing new technology that can reduce costs and simplify installation. At the production site of a multinational healthcare diagnostic test manufacturer, Bürkert’s FLOWave has proven...

Lung cancer treatment is a UK first

A grandfather has become the UK’s first lung cancer patient to benefit from a state-of-art radiotherapy treatment at The Christie NHS Foundation Trust. Barry Staniforth, 81, was treated using the Elekta MR-guided linear accelerator (MR-linac) machine that performs real-time MRI...

Novel mechanism links IBD genetic defect to gut leakiness

A study into ‘leaky gut’ is the first to show how a disease mutation increases the risk of developing Inflammatory Bowel Disease (IBD). Researchers led by a biomedical scientist at the University of California, Riverside, have identified a novel mechanism...

New approach will help identify drugs that can ‘glue’ proteins together

A new screening method that can test the effectiveness of therapeutic molecules designed to ‘glue’ proteins together in the body has been developed by researchers at the University of Birmingham and the University of Leicester. The research paves the way...

Protecting Digital Medtech Innovation

For many years the medical technology (medtech) sector has been at the forefront of innovation and the Covid-19 pandemic has not slowed it down, with new technology quickly being developed to test for, prevent and treat the virus. Protecting medtech...

Antimicrobial resistance ‘arms race’ heats up

An advanced interventional microbiomics company, which is developing non-antibiotic methods for the control of multiple-drug resistant superbugs and other infectious disease, is stepping up development of a cure for antibiotic resistant bacteria. BioPlx has set out to control and combat...

Breakthrough on horizon for superior bovine mastitis cure

Advanced studies into adjunct therapy in bovine mastitis are set to start. The condition is a significant economic and animal welfare issue for global dairy farmers, and this study, by Anifera, will build on promising initial data. It follows a...

Large-scale drug analysis reveals potential new COVID-19 antivirals

Researchers at the Francis Crick Institute and University of Dundee have screened thousands of drug and chemical molecules and identified a range of potential antivirals that could be developed into new treatments for COVID-19 or in preparation for future...

Artificial heart is successfully implanted

A bioprosthetic artificial heart has been implanted in a critically ill patient for only the third time ever in a commercial setting. The Aeson® device – heralded as the world’s most advanced total artificial heart - offers a therapeutic alternative...

Taster webinar announced ahead of first-ever approved qualification in the Management of Adaptation to Climate Change

Free registration: https://bookwhen.com/resiliencetoclimatechange/e/ev-szx9-20210930110000 Date & Time: Thursday 30 September, 11AM-12PM Ahead of the first delivery of the new Level 5 Certificate in the Management of Adaptation to Climate Change, the first-ever approved professional qualification in this subject, Climate Sense and Learning...

Connect 2 Cleanrooms delivers solid-state battery production cleanroom for Ilika

Connect 2 Cleanrooms Ltd (C2C) has completed a new 340m2 cleanroom facility for Ilika PLC at its 1600m2 Stereax—millimetre-scale solid-state batteries—manufacturing facility. The cleanroom is a key element of Ilika’s new facility as it scales up Stereax, to become the first volume manufacturer of micro-batteries for next-generation MedTech...

Creating a repeatable environment for micro moulding

For injection moulders, upgrading plastics manufacturing with a cleanroom to gain access to medical markets is a common move and a natural progression pathway. Over the years, Connect 2 Cleanrooms (C2C) has provided modular cleanrooms to support many organisations...

The scientific, political and economic implications of COVID-19: an insider’s perspective

It is widely assumed that the life science industry performed well off the back of the COVID-19 pandemic, with the demand for assays and molecular tools driving unprecedented sales to support global research. This may be true in the...

AGMA extends production with large softwall cleanroom

AGMA is a trusted global leader in bespoke chemical manufacturing. During the COVID-19 pandemic, demand for its products has been high and it has been AGMA’s objective to keep a continuous supply of its chemicals to its customer base. Despite...

FREE WEBINAR ANNOUNCED IN ADAPTATION TO CLIMATE CHANGE

Climate resilience experts, Climate Sense, and water industry training provider, Learning & Development Associates (L&DA), have announced a free webinar on adaptation to climate change following the launch of their new qualifications. The first step on a learning journey that...

New Jurassic flying reptile has the oldest opposed thumb

A new 160-million-year-old arboreal pterosaur species, dubbed ‘Monkeydactyl’, has the oldest true opposed thumb - a novel structure previously not known in pterosaurs. An international team of researchers from China, Brazil, UK, Denmark and Japan have described a new Jurassic...

THE FORCE OF LIVING CELLS EXERTED AT WARP SPEED MEASURED

Scientists at the University of St Andrews have learned to measure the tiniest forces living cells exert at sheer WARP speed. As first published in Nature Communications, the team of researchers, led by the School of Physics and Astronomy, have...

SAGES TEACH THE ART OF ADAPTING TO CLIMATE CHANGE

While the conversation about climate change has been dominated by mitigation, what is equally crucial is the need to adapt to the unavoidable changes already on their way. “We have absolutely no choice but to learn to adapt to...

TWO NEW FORMS OF THERAPY GIVE HOPE WHEN BLOOD CANCER RETURNS AND BOWEL CANCER SPREADS

Scientists trial new way to boost CAR T-cell therapy Cancer Research UK is collaborating with Aleta Biotherapeutics to trial a new therapy that reboots a treatment for some people whose blood cancer starts to come back. The new therapy, called ALETA-001, aims to...

A transformative roadmap for neurotechnology in the UK

Innovation experts, KTN, publish roadmap calling for multi-million pound investment to develop and commercialise ground-breaking treatments for disorders of the brain and nervous system. The human brain remains one of the great unknown frontiers and the more we understand about...